PHK
PGNX

Point72 Hong Kong’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Point72 Hong Kong’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,267
Closed -$19K – 1262
2017
Q4 		$19K Buy
+3,267
New +$19.8K 0.01% 381
2017
Q2 		– Sell
-78
Closed -$1K – 1115
2017
Q1 		$1K Buy
+78
New +$779 ﹤0.01% 701
2016
Q4 		– Sell
-11,500
Closed -$73K – 1105
2016
Q3 		$73K Buy
+11,500
New +$69.5K 0.04% 401

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Point72 Hong Kong's PGNX Position: Q1 2018 in Review

Point72 Hong Kong sold out of Progenics Pharmaceuticals Inc (PGNX) in Q1 2018, closing a stake of 3,267 shares — an estimated $19K sold.

Point72 Hong Kong first reported a position in PGNX in Q3 2016 and held it in 3 quarters. The position peaked at $73K in Q3 2016. 152 funds tracked by Wall St. Rank hold PGNX as of Q1 2018.

  • Point72 Hong Kong reported no remaining Progenics Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
  • Point72 Hong Kong sold 3,267 Progenics Pharmaceuticals Inc shares in Q1 2018, an estimated $19K.
  • Point72 Hong Kong first reported a position in Progenics Pharmaceuticals Inc in Q3 2016 and held it in 3 quarters.
  • Point72 Hong Kong's Progenics Pharmaceuticals Inc position peaked at $73K in Q3 2016.
  • 152 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2018.

Based on Point72 Hong Kong's 13F filing for Q1 2018, filed 15 May 2018.